Kaposi sarcoma-associated herpesvirus (KSHV) induces a functional tumor-associated phenotype for oral fibroblasts

Cancer Letters

Volumn 318, Issue 2, 2012, Pages 214-220

  Dai, Lu ^a,b,c   Qin, Zhiqiang ^a,b,c   Defee, Michael ^b   Toole, Bryan P ^a   Kirkwood, Keith L ^b   Parsons, Chris ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Kaposi sarcoma; KSHV; Pathogenesis

Indexed keywords

CD147 ANTIGEN; CYTOKINE; EARLY GROWTH RESPONSE FACTOR 2; TRANSCRIPTION FACTOR SP1; VASCULOTROPIN;

ARTICLE; CANCER INVASION; CONTROLLED STUDY; CYTOKINE RELEASE; FIBROBLAST; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; LATENT VIRUS INFECTION; MOUTH CAVITY; MOUTH TUMOR; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ANTIGENS, CD147; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; HERPESVIRUS 8, HUMAN; HUMANS; MOUTH; MOUTH NEOPLASMS; PHENOTYPE; POLYMERASE CHAIN REACTION;

HUMAN HERPESVIRUS 8;

EID: 84858151605     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.12.019     Document Type: Article

References (32)

1. Engels E.A., Biggar R.J., Hall H.I., Cross H., Crutchfield A., Finch J.L., Grigg R., Hylton T., Pawlish K.S., McNeel T.S., Goedert J.J. Cancer risk in people infected with human immunodeficiency virus in the United States. Int. J. Cancer 2008, 123:187-194.
2. Feller L., Lemmer J., Wood N.H., Jadwat Y., Raubenheimer E.J. HIV-associated oral Kaposi sarcoma and HHV-8: a review. J. Int. Acad. Periodontol. 2007, 9:129-136.
3. Miller C.S., Berger J.R., Mootoor Y., Avdiushko S.A., Zhu H., Kryscio R.J. High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy. J. Clin. Microbiol. 2006, 44:2409-2415.
4. Flaitz C.M., Jin Y.T., Hicks M.J., Nichols C.M., Wang Y.W., Su I.J. Kaposi's sarcoma-associated herpesvirus-like DNA sequences (KSHV/HHV-8) in oral AIDS-Kaposi's sarcoma: a PCR and clinicopathologic study. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 1997, 83:259-264.
5. Rohrmus B., Thoma-Greber E.M., Bogner J.R., Rocken M. Outlook in oral and cutaneous Kaposi's sarcoma. Lancet 2000, 356:2160.
6. Ramirez-Amador V., Martinez-Mata G., Gonzalez-Ramirez I., Anaya-Saavedra G., de Almeida O.P. Clinical, histological and immunohistochemical findings in oral Kaposi's sarcoma in a series of Mexican AIDS patients. Comparative study. J. Oral Pathol. Med. 2009, 38:328-333.
7. Crawford Y., Kasman I., Yu L., Zhong C., Wu X., Modrusan Z., Kaminker J., Ferrara N. PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. Cancer Cell 2009, 15:21-34.
8. Mueller L., Goumas F.A., Affeldt M., Sandtner S., Gehling U.M., Brilloff S., Walter J., Karnatz N., Lamszus K., Rogiers X., Broering D.C. Stromal fibroblasts in colorectal liver metastases originate from resident fibroblasts and generate an inflammatory microenvironment. Am. J. Pathol. 2007, 171:1608-1618.
9. Gaggioli C., Hooper S., Hidalgo-Carcedo C., Grosse R., Marshall J.F., Harrington K., Sahai E. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat. Cell Biol. 2007, 9:1392-1400.
10. Akula S.M., Naranatt P.P., Walia N.S., Wang F.Z., Fegley B., Chandran B. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) infection of human fibroblast cells occurs through endocytosis. J. Virol. 2003, 77:7978-7990.
11. Qin Z., Dai L., Toole B., Robertson E., Parsons C. Regulation of Nm23-H1 and cell invasiveness by Kaposi's sarcoma-associated herpesvirus. J. Virol. 2011, 85:3596-3606.
12. Adang L.A., Parsons C.H., Kedes D.H. Asynchronous progression through the lytic cascade and variations in intracellular viral loads revealed by high-throughput single-cell analysis of Kaposi's sarcoma-associated herpesvirus infection. J. Virol. 2006, 80:10073-10082.
13. Ballestas M.E., Chatis P.A., Kaye K.M. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 1999, 284:641-644.
14. Li R., Huang L., Guo H., Toole B.P. Basigin (murine EMMPRIN) stimulates matrix metalloproteinase production by fibroblasts. J. Cell. Physiol. 2001, 186:371-379.
15. Cotter M.A., Robertson E.S. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. Virology 1999, 264:254-264.
16. Yoo S.M., Zhou F.C., Ye F.C., Pan H.Y., Gao S.J. Early and sustained expression of latent and host modulating genes in coordinated transcriptional program of KSHV productive primary infection of human primary endothelial cells. Virology 2005, 343:47-64.
17. Mesri E.A., Cesarman E., Boshoff C. Kaposi's sarcoma and its associated herpesvirus. Nat. Rev. Cancer 2010, 10:707-719.
18. Qin Z., Kearney P., Plaisance K., Parsons C.H. Pivotal advance: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes. J. Leukoc. Biol. 2010, 87:25-34.
19. Yan L., Zucker S., Toole B.P. Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression. Thromb. Haemost. 2005, 93:199-204.
20. Qin Z., Dai L., Slomiany M.G., Toole B.P., Parsons C. Direct activation of emmprin and associated pathogenesis by an oncogenic herpesvirus. Cancer Res. 2010, 70:3884-3889.
21. Liang L., Major T., Bocan T. Characterization of the promoter of human extracellular matrix metalloproteinase inducer (EMMPRIN). Gene 2002, 282:75-86.
22. Kong L.M., Liao C.G., Fei F., Guo X., Xing J.L., Chen Z.N. Transcription factor Sp1 regulates expression of cancer-associated molecule CD147 in human lung cancer. Cancer Sci. 2010, 101:1463-1470.
23. Igarashi K., Sun J. The heme-Bach1 pathway in the regulation of oxidative stress response and erythroid differentiation. Antioxid. Redox Signaling 2006, 8:107-118.
24. Ishii T., Itoh K., Takahashi S., Sato H., Yanagawa T., Katoh Y., Bannai S., Yamamoto M. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J. Biol. Chem. 2000, 275:16023-16029.
25. Loeffler M., Kruger J.A., Niethammer A.G., Reisfeld R.A. Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. J. Clin. Invest. 2006, 116:1955-1962.
26. Defee M.R., Qin Z., Dai L., Toole B.P., Isaacs J.S., Parsons C. Extracellular Hsp90 serves as a co-factor for NF-κB activation and cellular pathogenesis induced by an oncogenic herpesvirus. Am. J. Cancer Res. 2011, 1:686-699.
27. M.E. Alves, A. Mohammadi, A.L. Naief, L.F. Moreira, Localized acute periodontitis due to alveolar bone invasion by Kaposi's sarcoma (KS). Program Abstract: First National Conference on Human Retroviruses and Related Infections. Washington, DC. 1993, No. 146.
28. Aoki Y., Jones K.D., Tosato G. Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. J. Hematother. Stem Cell Res. 2000, 9:137-145.
29. Sakakibara S., Tosato G. Viral interleukin-6: role in Kaposi's sarcoma-associated herpesvirus-associated malignancies. J. Interferon Cytokine Res. 2011, July 18, epub ahead of print.
30. Riva G., Barozzi P., Torelli G., Luppi M. Immunological and inflammatory features of Kaposi's sarcoma and other Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8-associated neoplasias. AIDS Rev. 2010, 12:40-51.
31. Gasperini P., Sakakibara S., Tosato G. Contribution of viral and cellular cytokines to Kaposi's sarcoma-associated herpesvirus pathogenesis. J. Leukoc. Biol. 2008, 84:994-1000.
32. Verma S.C., Borah S., Robertson E.S. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1. J. Virol. 2004, 78:10348-10359.